December 3, 2020
Business News

US FDA grants emergency use authorization to Regeneron COVID-19 antibody given to Trump – Fox Business

The U.S. Food and Drug Administration on Saturday issued emergency use authorization for Regeneron Pharmaceuticals Inc’s COVID-19 antibody therapy, an experimental treatment given to U.S. President Donald Trump that he said helped cure him of the disease.
The FDA said the monoclonal antibodies, casirivimab and imdevimab, should be administered together for the treatment of mild to moderate COVID-19 in adults and pediatric patients with positive results of direct SARS-CoV-2 viral testing and who…

Click here to view the original article.

Related Posts

You might also like ...

KBRA Releases ABS East 2020 Virtual Conference Recap
Aptar Named One of the “Most Responsible Companies in France” by Le Point
AON Splash Image
Tilly’s, Inc. Announces Fiscal 2020 Third Quarter Operating Results, Provides Fourth Quarter Business Update